Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

News

Vator Securities appoints Therese Carlborg as COO

6 November 2017

Therese Carlborg is appointed Chief Operating Officer (COO) at Vator Securities. Therese will be appointed on September 4, 2017. She was previously the Government Affairs Director at pharmaceutical company AbbVie and has served as Political Secretary to Filippa Reinfeldt.

Read More

Vator Securities advises Immunovia in record breaking capital raise

20 October 2016

The capital raise of SEK 218.7 million, which was divided into a private placement share issue of SEK 189.9 million and a rights issue of SEK 28.7 million, broke the record for raising of capital for a diagnostics company on NASDAQ First North Stockholm.

Read More

Vator Securities successfully completes advisory mission for Biovica

21 June 2016

Vator Securities, a securities company specializing in financial advisory services for fast-growing companies, today announced the completion of a capital raise in an oversubscribed new share issue of SEK 30 million for Biovica International AB. 

Read More

Vator Securities successfully completes advisory mission for IRRAS

3 May 2016

Vator Securities today announced the completion of a SEK 91.2 million capital raise for IRRAS AB. IRRAS AB is a commercial medical technology company that develops and sells a groundbreaking pump and catheter system for the treatment of cerebral hemorrhage.

Read More

Lars Träff appointed new industrial advisor to Vator Securities

11 March 2016

Stockholm, February 26, 2016 – Vator Securities, the investment bank for innovative and rapidly growing companies, recruits Lars Träff as new industrial advisor.

Read More

Maris Hartmanis appointed new industrial advisor to Vator Securities

24 February 2016

Stockholm, February 24, 2016 – Vator Securities, the investment bank for innovative and rapidly growing companies, recruits Maris Hartmanis as new industrial advisor.

Read More

Immunovia’s new share issue subscribed to a value of SEK 305 million

19 November 2015

The rights issue of Immunovia AB (publ) (“Immunovia” or ” the Company”) for the Company’s listing on Nasdaq First North was subscribed to SEK 305 million, which corresponds to a subscription ratio of approximately 500 percent.

Read More

Vator Securities successfully completes advisory mission for Vikingaliv

11 June 2015

Vator Securities acted as exclusive financial advisor for Vikingaliv and assisted with obtaining both bank financing and share capital.

Read More